The development of the hypothalamic paraventricular nucleus (PVN) involves several factors that work together to establish a cell group that regulates neuroendocrine functions and behaviors. A number of molecular markers were noted within the developing PVN, including estrogen receptors (ER), neuronal nitric oxide synthase (nNOS) and brain derived neurotrophic factor (BDNF). By contrast, immunoreactive gamma-aminobutyric acid (GABA) was found in cells and fibers surrounding the PVN. Two animal models were used to test the hypothesis that GABA works through GABAA and GABAB receptors to influence the development of the PVN. Treatment with bicuculline to decrease GABAA receptor signaling from embryonic day (E)10 to 17 resulted in fewer cells containing immunoreactive (ir)-ERα in the region of the PVN versus control. GABABR1 receptor subunit knockout mice were used to examine the PVN at P0 without GABAB signaling. In female but not male GABABR1 subunit knockout mice, the positions of cells containing ir-ERα shifted from medial to lateral compared to wildtype controls, while the total number of ir-ERα containing cells was unchanged. In E17 knockout mice, ir-nNOS cells and fibers were spread over a greater area. There was also a significant decrease in ir-BDNF in the knockout mice in a region dependent manner. Changes in cell position and protein expression subsequent to disruption of GABA signaling may be due, in part, to changes in nNOS and BDNF signaling. Based on the current study, the PVN can be added as another site where GABA exerts morphogenetic actions in development.